Purple Biotech Ltd.PPBTNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank27
3Y CAGR-20.4%
5Y CAGR-13.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-20.4%/yr
vs -2.3%/yr prior
5Y CAGR
-13.5%/yr
Recent deceleration
Acceleration
-18.1pp
Decelerating
Percentile
P27
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $2.94M | -39.4% |
| 2023 | $4.84M | -18.8% |
| 2022 | $5.96M | +2.4% |
| 2021 | $5.82M | +2.0% |
| 2020 | $5.71M | -6.1% |
| 2019 | $6.08M | +17.2% |
| 2018 | $5.19M | -18.8% |
| 2017 | $6.39M | +112.9% |
| 2016 | $3.00M | +99.0% |
| 2015 | $1.51M | - |